38.92
-1.76(-4.33%)
Currency In USD
| Previous Close | 40.68 |
| Open | 40.9 |
| Day High | 41.51 |
| Day Low | 38.9 |
| 52-Week High | 103.81 |
| 52-Week Low | 37.12 |
| Volume | 889,666 |
| Average Volume | 1.06M |
| Market Cap | 2.17B |
| PE | -25.27 |
| EPS | -1.54 |
| Moving Average 50 Days | 48.65 |
| Moving Average 200 Days | 63.12 |
| Change | -1.76 |
If you invested $1000 in PROCEPT BioRobotics Corporation (PRCT) since IPO date, it would be worth $927.99 as of September 09, 2025 at a share price of $38.92. Whereas If you bought $1000 worth of PROCEPT BioRobotics Corporation (PRCT) shares 3 years ago, it would be worth $768.41 as of September 09, 2025 at a share price of $38.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
GlobeNewswire Inc.
Jul 24, 2025 10:00 PM GMT
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48% SAN JOSE, Calif., July 24, 2025
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
GlobeNewswire Inc.
Jul 23, 2025 12:00 PM GMT
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that thre
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire Inc.
Jul 21, 2025 8:03 PM GMT
SAN JOSE, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it